Jonathan Pai - Concepedia

Author

Jonathan Pai

Stanford University ORCID

Also Known As

J Pai, J. Pai, J.S. Pai, Jonathan Pai, Jonathan S Pai, Jonathan S. Pai, Pai, Jonathan, Pai, Jonathan S.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Stanford University Johns Hopkins University University of California, San Francisco Johns Hopkins Medicine Stanford Cancer Institute

About

Jonathan Pai is an author at Stanford University specializing in medicine, health sciences, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	213
2	Medicine	4	4	213
3	Surgical Oncology	3	3	136
4	Radiation Medicine	1	1	73
5	Adaptive Radiotherapy	1	1	73

Jonathan Pai

Publications

949

Citations

H-Index

Page 1

	Year	Citations
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma Joseph M. Herman, Daniel T. Chang, Karyn A. Goodman, Cancer	2014	526
Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy Avani Satish Dholakia, Muhammad Chaudhry, Jeffrey P. Leal, International Journal of Radiation OncologyBiologyPhysics Survival OutcomesOncologyPancreatic CancerRadiation TherapyMedicine	2014	77
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. Aaron T. Wild, Susan M. Hiniker, Daniel T. Chang, PubMed Adaptive RadiotherapyRadiation MedicineSurgical OncologyPancreatic CancerRadiation Therapy	2013	73
The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer Margaret M. Kozak, Rie von Eyben, Jonathan Pai, American Journal of Clinical Oncology	2015	52
Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer Margaret M. Kozak, Eric M. Anderson, Rie von Eyben, Pancreas	2015	50
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer Margaret M. Kozak, Rie von Eyben, Jonathan Pai, Journal of Clinical Pathology	2015	47
Factors Associated with Osteoid Osteoma Recurrence after CT-Guided Radiofrequency Ablation Joe D. Baal, Jonathan Pai, William Chen, Journal of Vascular and Interventional Radiology Surgical OncologyBone ImagingMedical ImagingOsteoid Osteoma RecurrenceInterventional Radiology	2019	37
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer Avani D. Rao, Elizabeth A. Sugar, Daniel T. Chang, Practical Radiation Oncology Surgical OncologyPatient-reported OutcomesPancreatic CancerRadiation TherapyMedicine	2016	26
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3 David Shultz, Jonathan Pai, Wayland Chiu, PLoS ONE	2016	17
Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes Joe D. Baal, William Chen, David A. Solomon, American Journal of Neuroradiology	2019	15

Page 1